
Pharmaceutical companies have already begun developing these boosters, and Haydock said he expects to see some variant-specific vaccines available by mid-2021.
Pharmaceutical companies have already begun developing these boosters, and Haydock said he expects to see some variant-specific vaccines available by mid-2021.
Errors related to extended-release opioids and COVID-19 vaccines warrant attention and should be a priority.
Nearly half of independent pharmacists surveyed by the National Community Pharmacists Association are not getting enough or any doses of the COVID-19 vaccine.
As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.
The FDA and CDC said that 6 women experienced cerebral venous thrombosis, an extremely rare disorder associated with blood clotting, 6 to 16 days after the Johnson & Johnson COVID-19 vaccine was administered.
COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
The most common reason given for refusal of a COVID-19 vaccine was distrust of the health care system, correctional or government personnel, and institutions.
Indicators of the COVID-19 pandemic’s impact, including testing rates, positivity ratio, case rates by overall population, and deaths, are clustered by neighborhood, with low-income and predominantly minority communities experiencing worse outcomes.
Patricia Stinchfield, the president-elect of National Foundation for Infectious Diseases, discusses the recommended framework for vaccine messaging for leaders across sectors.
For the study, the research team modeled COVID-19 transmission rates and the optimal allocation of an initially limited vaccine supply in the United States under a variety of scenarios.
After reviewing the mechanisms of the first three COVID-19 vaccines granted emergency use authorization, we can now address some of the most common concerns that have been expressed regarding vaccine hesitancy.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week
The Pfizer and BioNTech vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 variant is prevalent.
Patients who received a flu shot during the last flu season were significantly less likely to test positive for a COVID-19 infection at the start of the pandemic, according to a study published in the American Journal of Infection Control.
Pharmacist-led services are not only important during COVID-19 immunization efforts in the United States, but are additionally critical in vaccination endeavors globally.
The results from a phase 3 trial in a population of American adolescents aged 12 to 15 years found that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 showed 100% efficacy and robust antibody responses.
The Biden administration has moved to activate 40,000 local pharmacies within the Federal Retail Pharmacy Program, which is a part of the administration’s national COVID-19 vaccination strategy.
The APhA and the CDC announced that they have entered into a collaborative agreement focused on supporting the role of pharmacists in building the public’s confidence in COVID-19 vaccines.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Daily national surveys by Carnegie Mellon University (CMU) show that although COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged.
The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.
A prognostic COVID-19 Severity Test has been launched for the identification of high-risk individuals who are likely to experience the most severe COVID-19 complications upon exposure to the virus.
Researchers found no evidence that protection against COVID-19 reinfection declined within a 6-month follow-up period.
As the pandemic has continued, it has helped shine a light on how important pharmacists, pharmacy interns, and pharmacy technicians can help impact their communities.
Shoulder injuries are a real concern because some health care workers may be new to administering vaccines.